Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
about
Heart Failure: Diagnosis, Management and UtilizationSystematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infectionsListening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes PathogenesisThe contributory role of gut microbiota in cardiovascular diseaseThe gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseasesEffect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A ReviewAssociations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults.Trimethylamine N-Oxide: The Good, the Bad and the UnknownIntestinal Microbiota Metabolism and AtherosclerosisEgg phospholipids and cardiovascular healthNon-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of AtherosclerosisThe gut microbiome in cardio-metabolic health.Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.Microbial trimethylamine-N-oxide as a disease marker: something fishy?Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function.Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.A plant-based diet and heart failure: case report and literature reviewMicrobiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAOGut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney diseaseIntestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failureTransmission of atherosclerosis susceptibility with gut microbial transplantation.Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.Dysbiosis of Gut Microbiota With Reduced Trimethylamine-N-Oxide Level in Patients With Large-Artery Atherosclerotic Stroke or Transient Ischemic Attack.Brief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus.Exploring the Microbiome in Heart FailureGut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis RiskGastroenterologist perceptions of faecal microbiota transplantation.Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.Gut Microbiota in Cardiovascular Health and Disease.Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention Program.Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart FailureAssociations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional studyMicrobiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA)Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion.Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice.
P2860
Q26745543-BD48C6BA-A61E-4A52-B15D-FC3D863187C7Q26782662-C7F59817-3CF2-4798-80A8-8C1C42B20F74Q26823198-4AF001ED-1724-46B5-BEE6-5FE63C440A8AQ26830828-262AE749-B15A-4A3C-8F6A-1F88F3D387A1Q27021692-FDC01132-CD26-4CDC-B8D2-DCE74B714E8BQ27023183-37711BA6-E097-4828-B493-E2106B38D390Q27302142-73066FC3-1BDD-4404-A144-A89FB2FEBD41Q28079182-5A40469C-AF10-483A-9500-44A31500CC95Q28081862-A6031621-D5CD-4500-8B1A-EAB3939233CBQ28082796-C9874B49-FE10-4F55-960C-1854FD83B654Q29038812-D9406B89-FDF6-4E02-B433-4C2B03EAA8B7Q30373247-A294A030-D005-4964-B144-41093444262AQ33613115-28069714-805D-493F-B569-1C06608C953FQ33727107-2D94D546-F26B-4AF0-915C-FFA2B366857FQ33731986-882BB18F-ECF8-4F54-BC68-35E464B5952AQ33749467-D2AA1B82-2038-4488-8BA1-AB68623213FFQ33785595-13430E52-C8E3-4F95-A551-785B717BA508Q33827624-5B4D3339-C0D6-4A2F-A848-A74E5C1AB669Q34630290-B50375EA-5C2D-4E7F-BE7A-406B1EEB888FQ35033613-DB9E6C23-5DCE-4928-9762-39EBE429F36BQ35034335-1DC349FC-99EE-4FB6-A9D9-52E288B8BEE5Q35126669-030205C9-2686-4F54-8E10-D1F21B7BF9C3Q35798608-654A654C-3A26-4E3F-BD9F-3C0DB1CD1788Q35819570-829768CF-1538-4FD4-A0B9-8C7FF610F754Q35849053-BEE77274-902D-4B5F-A267-38B6763EC1E2Q35908640-E822ACE8-C6A5-49E6-AD1A-764DA5A9CBF9Q35926145-02EFEF32-868B-47AE-A8E2-6131D1A3E76DQ35955435-C21DB52C-A9BD-4557-A982-E9D9A74B498CQ36145301-033FEBB4-90A6-4086-988D-FFFF199B8C63Q36318399-1A867418-7A7E-4B4B-8867-4D4F73DA43D3Q36329055-6A0B9A76-7B7D-4B5F-8A81-6A773D416008Q36340545-3D5CCDB6-B75A-4971-AF8D-329E383369BBQ36820745-108C8CBB-999B-4753-976C-859D18A4FD6DQ36827878-0CA0FC85-B0AF-4524-924A-E3A6DE29A351Q37076037-22D91016-7973-458E-A406-BE2AAFAD5EE6Q37090184-6FC81065-1685-43EE-B9D9-31C8394C0933Q37310131-F1397EAB-C3FE-406D-B7A3-53ACEB908D53Q37434694-37715221-D5AB-4E12-8683-75C769EB2568Q37677259-FA7B9433-B3AD-4EB1-A186-8F0B465158F9Q37712604-A5574677-6799-459D-BEF2-C3385DAC0ED2
P2860
Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prognostic value of elevated l ...... : refining the gut hypothesis.
@ast
Prognostic value of elevated l ...... : refining the gut hypothesis.
@en
Prognostic value of elevated l ...... : refining the gut hypothesis.
@nl
type
label
Prognostic value of elevated l ...... : refining the gut hypothesis.
@ast
Prognostic value of elevated l ...... : refining the gut hypothesis.
@en
Prognostic value of elevated l ...... : refining the gut hypothesis.
@nl
prefLabel
Prognostic value of elevated l ...... : refining the gut hypothesis.
@ast
Prognostic value of elevated l ...... : refining the gut hypothesis.
@en
Prognostic value of elevated l ...... : refining the gut hypothesis.
@nl
P2093
P2860
P1476
Prognostic value of elevated l ...... : refining the gut hypothesis.
@en
P2093
Jennie E Hazen
Lillian M Donahue
Stanley L Hazen
W H Wilson Tang
Yiying Fan
P2860
P304
P356
10.1016/J.JACC.2014.02.617
P407
P577
2014-10-27T00:00:00Z